XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenues $ 653.5 $ 690.3 $ 2,007.3 $ 2,034.4
Cost of revenues 407.8 424.1 1,249.5 1,263.3
Gross profit 245.7 266.2 757.8 771.1
Selling, general and administrative expenses 217.3 215.6 654.2 676.5
Divestiture losses, net 4.2 0.0 63.4 0.0
Income from operations 24.2 50.6 40.2 94.6
Interest expense, net (17.4) (19.8) (56.9) (54.6)
Other income (expense), net 0.1 2.3 (0.3) 0.8
Income (loss) before income taxes 6.9 33.1 (17.0) 40.8
Income tax expense (4.8) (5.1) (19.1) (16.4)
Net income (loss) 2.1 28.0 (36.1) 24.4
Net income attributable to noncontrolling interests (0.1) 0.0 (0.2) (0.2)
Net income (loss) attributable to Stericycle, Inc. common shareholders $ 2.0 $ 28.0 $ (36.3) $ 24.2
Income (loss) per common share attributable to Stericycle, Inc. common shareholders:        
Basic (in dollars per share) $ 0.02 $ 0.30 $ (0.39) $ 0.26
Diluted (in dollars per share) $ 0.02 $ 0.30 $ (0.39) $ 0.26
Weighted average number of common shares outstanding:        
Basic (in shares) 92.5 92.2 92.4 92.1
Diluted (in shares) 92.9 92.4 92.4 92.4